Search Results 171-180 of 1283 for ☃휴대폰소액결제현금화 (010-9675-8884) 카톡 ON8884 콘텐츠이용료소액결제☃

  1. M6620 First in Human Study - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Hodgkin's Lymphoma Clinical Trials

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  3. Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation - Mayo Clinic

    About this study. The purpose of this study is to evaluate safety and tolerability as well as the effects of RM-131 on colonic motor and sensory effects in ...

  4. Nailfold Video Capillaroscopy Testing with Esophageal Dysmotility in Patients with Systemic Sclerosis - Mayo Clinic

    About this study. The purpose of this study is to assess findings on nailfold video capillaroscopy (NVC) and their association with esophageal dysfunction, ...

  5. Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

    This is a multicenter, international, double-blind study of the administration of mavacamten in participants with symptomatic obstructive HCM (oHCM).

  6. A Study to Evaluate Docetaxel With or Without Bintrafusp Alfa to Treat Patients with Advanced Non-small Cell Lung Cancer - Mayo Clinic

    The purpose of this study is to compare the progression-free survival (PFS) of docetaxel in combination with bintrafusp alfa vs. docetaxel alone. Participation ...

  7. Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

    About this study. This is a Phase 1b, open label, multi-center study of CMB305 (sequentially administered LV305 [a dendritic cell-targeting viral vector ...

  8. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    After completing all screening assessments and meeting all eligibility criteria, subjects will be randomized to receive placebo or AMG 181 at various doses per ...

  9. A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies - Mayo Clinic

    A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in ...

  10. A Study to Evaluate Chest Pain Risk Stratification Using HEART Pathway in Community Emergency Departments - Mayo Clinic

    About this study. The objectives of this study are to evaluate utilization of chest pain risk stratification tools in a community hospital emergency ...